• LAST PRICE
    3.3500
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    3.0000/ 1
  • Ask / Lots
    5.3400/ 2
  • Open / Previous Close
    3.4100 / 3.3500
  • Day Range
    Low 3.3100
    High 3.5500
  • 52 Week Range
    Low 2.9600
    High 21.5800
  • Volume
    169,206
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 3.35
TimeVolumeKRON
09:32 ET16093.32
09:39 ET4003.38
09:41 ET1003.37
09:43 ET25003.41
09:48 ET5963.3501
09:52 ET163603.32
09:57 ET5003.35
10:03 ET2003.37
10:06 ET1003.37
10:08 ET17713.37
10:10 ET6003.39
10:12 ET105003.41
10:15 ET2003.4301
10:17 ET1003.46
10:24 ET7003.46
10:28 ET3003.45
10:32 ET12003.45
10:37 ET2003.48
10:39 ET8003.51
10:42 ET1043.505
10:44 ET160013.53
10:46 ET5323.54
10:48 ET15343.5
10:50 ET122003.46
10:51 ET65043.5
10:53 ET6493.48
10:55 ET4003.475
10:57 ET15203.5
11:00 ET3603.5
11:02 ET13303.5
11:04 ET8003.4901
11:06 ET7663.5
11:08 ET3003.5
11:09 ET2003.5
11:11 ET7373.5
11:13 ET1003.51
11:18 ET12003.53
11:20 ET9003.54
11:24 ET1003.55
12:18 ET2003.44
12:23 ET2093.43
12:32 ET6003.4476
12:34 ET4003.449
12:36 ET1003.45
12:38 ET1003.46
12:43 ET33993.46
12:48 ET30703.45
12:59 ET4923.44
01:01 ET1003.43
01:08 ET4003.44
01:15 ET2003.46
01:26 ET3003.41
01:28 ET1003.43
01:30 ET1003.44
01:37 ET1003.44
01:39 ET4003.43
01:42 ET10003.445
01:46 ET2003.44
01:48 ET1003.43
01:51 ET1003.41
01:57 ET1003.41
02:09 ET4613.4086
02:11 ET1003.41
02:15 ET3003.42
02:18 ET2003.44
02:29 ET1003.41
02:31 ET1003.4
02:36 ET3003.41
02:44 ET4003.39
02:47 ET13003.4
02:51 ET1003.4
02:56 ET2003.39
02:58 ET2003.37
03:00 ET9663.38
03:02 ET4003.375
03:03 ET3003.39
03:05 ET1503.3938
03:09 ET9443.4
03:14 ET1003.39
03:18 ET1003.385
03:23 ET2003.39
03:25 ET1003.38
03:27 ET2003.365
03:34 ET4053.35
03:36 ET2003.355
03:39 ET1003.36
03:43 ET3003.355
03:45 ET4003.35
03:48 ET38943.36
03:50 ET2003.355
03:52 ET5003.36
03:54 ET6003.355
03:56 ET16003.365
03:57 ET22003.355
03:59 ET14653.35
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesKRON
Kronos Bio Inc
199.8M
-1.1x
---
United StatesVKTX
Viking Therapeutics Inc
195.6M
-3.6x
---
United StatesFENC
Fennec Pharmaceuticals Inc
187.2M
-12.1x
---
United StatesACIU
AC Immune SA
207.2M
-3.4x
---
United StatesEVLO
Evelo Biosciences Inc
206.3M
-1.0x
---
United StatesETNB
89Bio Inc
204.4M
-1.1x
---
As of 2022-10-01

Company Information

Kronos Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of cancer therapeutics designed to target dysregulated transcription. Its product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks (TRNs) that drive their oncogenic activity. Its lead product candidate, entospletinib (ENTO), is an orally administered, selective spleen tyrosine kinase (SYK) inhibitor that is being developed for the treatment of acute myeloid leukemia (AML). Its second product candidate, KB-0742, is generated from its product engine’s small molecule microarray (SMM) platform. KB-0742 is designed to be an orally bioavailable inhibitor of CDK9 with a differentiated selectivity profile. Its KB-0742 is in advanced solid tumors with MYC genomic copy number gain (amplification).

Contact Information

Headquarters
1300 S. El Camino Real, Suite 400SAN MATEO, CA, United States 94402
Phone
212-871-7920
Fax
302-636-5454

Executives

Non-Executive Independent Chairman of the Board
Arie Belldegrun
President, Chief Executive Officer, Director
Norbert Bischofberger
Chief Financial Officer, Head of Corporate Development
Yasir Alwakeel
Chief Operating Officer, General Counsel
Barbara Kosacz
Executive Vice President - Clinical Development, Chief Medical Officer
Jorge Dimartino

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$199.8M
Revenue (TTM)
$0.00
Shares Outstanding
56.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.97
Book Value
$6.20
P/E Ratio
-1.1x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.